aid: bivacor
name: BiVACOR
description: 'BiVACOR, Inc. is a privately held, clinical-stage medical device company
  with corporate operations in Huntington Beach, California, clinical operations in
  Houston, Texas, and engineering operations on the Gold Coast, Queensland, Australia.
  It develops the BiVACOR Total Artificial Heart (TAH), a titanium biventricular rotary
  blood pump built around a single magnetically levitated rotor with a dual-sided impeller
  that replaces both ventricles of a failing heart, with no valves, flexing diaphragms
  or mechanical bearings, and flows above 12 L/min. Founded by Chief Technical Officer
  Daniel Timms, PhD, and led by CEO Jim Dillon with Chief Medical Officer William E.
  Cohn, MD, the company completed the first-in-human implantation at The Texas Heart
  Institute in July 2024 under an FDA Early Feasibility Study, received FDA Breakthrough
  Device Designation in May 2025, and was accepted into the FDA Total Product Life Cycle
  Advisory Program in August 2025. The TAH is an investigational device, limited by
  federal law to investigational use, and is not approved for commercial sale. BiVACOR
  is a medical hardware and clinical-research business - it publishes no developer
  program, public API, SDK, or machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/bivacor/refs/heads/main/apis.yml
image: https://bivacor.com/wp-content/uploads/2024/02/BIVACOR_Logo-300x64.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-07'
modified: '2026-08-07'
tags:
- Company
- Medical Devices
- Health Care
- Cardiology
- Heart Failure
- Total Artificial Heart
- Mechanical Circulatory Support
- Medical Technology
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/bivacor-domain-security.yml
- type: Conformance
  url: conformance/bivacor-conformance.yml
- type: LLMsTxt
  url: llms/bivacor-llms.txt
- type: Website
  url: https://bivacor.com/
- type: Blog
  url: https://bivacor.com/news/
- type: BlogRSS
  url: https://bivacor.com/feed/
- type: Press
  url: https://bivacor.com/media-coverage/
- type: Publications
  url: https://bivacor.com/publications/
- type: Careers
  url: https://jobs.ashbyhq.com/bivacor-inc
- type: Contact
  url: https://bivacor.com/#contact
- type: Support
  url: mailto:admin@bivacor.com
- type: LinkedIn
  url: https://www.linkedin.com/company/bivacor-pty-ltd
- type: Twitter
  url: https://x.com/bivacor
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/

x-enrichment:
  date: '2026-08-07'
  status: minimal
  artifacts_added: 4
  pass: local-v1

x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    BiVACOR is a clinical-stage medical device manufacturer whose product is an
    implantable titanium total artificial heart, not software; bivacor.com is a
    single-page WordPress marketing site whose 15-URL sitemap contains no developer, API
    or documentation path, and api./developer./docs./portal./status.bivacor.com have no
    DNS record at all - the only 200 on any contract-discovery path is /wp-json/, the
    stock WordPress REST API that ships enabled by default and is not a product API.
  evidence:
  - url: https://bivacor.com/openapi.json
    status: 404
  - url: https://bivacor.com/.well-known/agent-card.json
    status: 404
  - url: https://bivacor.com/.well-known/security.txt
    status: 404
  - url: https://bivacor.com/llms.txt
    status: 404
  - url: https://bivacor.com/sitemap.xml
    status: 200
  checked: '2026-08-07'